NEW YORK, Oct. 7, 2014 /PRNewswire/ --
AcelRx Pharmaceuticals, Inc.
Lifshitz & Miller announces that a class action
complaint was filed in the United States District Court for the
Northern District of California,
alleging that AcelRx Pharmaceuticals, Inc. ("ACRX") issued false
and misleading statements between December
2, 2013 and September 25,
2014. The complaint alleges among other things that: (a) the
IFU for Zalviso were not designed to adequately address the risk of
the inadvertent misplacement of tablets; and (b) ACRX had not
submitted to the FDA sufficient data to support the shelf life of
the product.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
Ambit Biosciences
Lifshitz & Miller announces an investigation into possible
breaches of fiduciary duties in connection with the proposed sale
of Ambit Biosciences ("AMBI") to Daiichi Sankyo Company, Ltd. in a
transaction valued at approximately $15 per share or up to $410 million, including, one CVR entitling the
holder to receive an additional cash payment of up to $4.50 for each share they own if certain
commercialization related milestones are achieved.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
Athlon Energy Inc.
Lifshitz & Miller announces an investigation into possible
breaches of fiduciary duties in connection with the proposed sale
of Athlon Energy Inc. ("ATHL") to Encana Corporation in a
transaction valued at approximately $7.1
billion or $58.50 per share,
as well as Encana assuming Athlon's $1.15
billion of senior notes.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
LipoScience, Inc.
Lifshitz & Miller announces an investigation into possible
breaches of fiduciary duties in connection with the proposed sale
of LipoScience, Inc. ("LPDX") to Laboratory Corporation of America
Holdings in a transaction valued at approximately $5.25 per share or $85.3
million.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
Simplicity Bancorp, Inc.
Lifshitz & Miller announces an investigation into possible
breaches of fiduciary duties in connection with the proposed sale
of Simplicity Bancorp, Inc. ("SMPL") to HomeStreet, Inc. SMPL
stockholders are expected to receive one share of HomeStreet common
stock for each share owned of SMPL common stock.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
TIBCO Software Inc.
Lifshitz & Miller announces an investigation into possible
breaches of fiduciary duties in connection with the proposed sale
of TIBCO Software Inc. ("TIBX") to Vista Equity Partners in a
transaction valued at approximately $4.3
billion or $24.00 per share.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
ATTORNEY ADVERTISING. © 2014 Lifshitz &
Miller. The law firm responsible for this advertisement is
Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)
493-9780. Prior results do not guarantee or predict a similar
outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com
SOURCE Lifshitz & Miller Law Firm